Jounce Therapeutics, Inc. Quarterly Current Ratio in % from Q3 2017 to Q4 2022

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Jounce Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2017 to Q4 2022.
  • Jounce Therapeutics, Inc. Current Ratio for the quarter ending December 31, 2022 was 773 %, a 46.1% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2022 773 -663 -46.1% Dec 31, 2022
Q3 2022 810 -647 -44.4% Sep 30, 2022
Q2 2022 965 -344 -26.3% Jun 30, 2022
Q1 2022 1.21K +105 +9.52% Mar 31, 2022
Q4 2021 1.44K +526 +57.8% Dec 31, 2021
Q3 2021 1.46K +536 +58.2% Sep 30, 2021
Q2 2021 1.31K +215 +19.7% Jun 30, 2021
Q1 2021 1.11K +550 +99% Mar 31, 2021
Q4 2020 910 +533 +141% Dec 31, 2020
Q3 2020 921 +620 +205% Sep 30, 2020
Q2 2020 1.09K +840 +330% Jun 30, 2020
Q1 2020 556 +262 +89.4% Mar 31, 2020
Q4 2019 377 +46 +13.9% Dec 31, 2019
Q3 2019 302 -56.3 -15.7% Sep 30, 2019
Q2 2019 254 -131 -33.9% Jun 30, 2019
Q1 2019 293 -89 -23.3% Mar 31, 2019
Q4 2018 331 -32.8 -9.03% Dec 31, 2018
Q3 2018 358 +58.8 +19.7% Sep 30, 2018
Q2 2018 385 Jun 30, 2018
Q1 2018 382 Mar 31, 2018
Q4 2017 364 Dec 31, 2017
Q3 2017 299 Sep 30, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.